Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis
dc.contributor.author | Selenica, Maj-Linda B | |
dc.contributor.author | Davtyan, Hayk | |
dc.contributor.author | Housley, Steven B | |
dc.contributor.author | Blair, Laura J | |
dc.contributor.author | Gillies, Anne | |
dc.contributor.author | Nordhues, Bryce A | |
dc.contributor.author | Zhang, Bo | |
dc.contributor.author | Liu, Joseph | |
dc.contributor.author | Gestwicki, Jason E | |
dc.contributor.author | Lee, Daniel C | |
dc.contributor.author | Gordon, Marcia N | |
dc.contributor.author | Morgan, Dave | |
dc.contributor.author | Dickey, Chad A | |
dc.date.accessioned | 2014-12-08T17:46:55Z | |
dc.date.available | 2014-12-08T17:46:55Z | |
dc.date.issued | 2014-09-03 | |
dc.identifier.citation | Journal of Neuroinflammation. 2014 Sep 03;11(1):152 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/109522 | en_US |
dc.description.abstract | Abstract Background Abnormal tau hyperphosphorylation and its accumulation into intra-neuronal neurofibrillary tangles are linked to neurodegeneration in Alzheimer’s disease and similar tauopathies. One strategy to reduce accumulation is through immunization, but the most immunogenic tau epitopes have so far remained unknown. To fill this gap, we immunized mice with recombinant tau to build a map of the most immunogenic tau epitopes. Methods Non-transgenic and rTg4510 tau transgenic mice aged 5 months were immunized with either human wild-type tau (Wt, 4R0N) or P301L tau (4R0N). Each protein was formulated in Quil A adjuvant. Sera and splenocytes of vaccinated mice were collected to assess the humoral and cellular immune responses to tau. We employed a peptide array assay to identify the most effective epitopes. Brain histology was utilized to measure the effects of vaccination on tau pathology and inflammation. Results Humoral immune responses following immunization demonstrated robust antibody titers (up to 1:80,000 endpoint titers) to each tau species in both mice models. The number of IFN-γ producing T cells and their proliferation were also increased in splenocytes from immunized mice, indicating an increased cellular immune response, and tau levels and neuroinflammation were both reduced. We identified five immunogenic motifs within either the N-terminal (9-15 and 21-27 amino acids), proline rich (168-174 and 220-228 amino acids), or the C-terminal regions (427-438 amino acids) of the wild-type and P301L tau protein sequence. Conclusions Our study identifies five previously unknown immunogenic motifs of wild-type and mutated (P301L) tau protein. Immunization with both proteins resulted in reduced tau pathology and neuroinflammation in a tau transgenic model, supporting the efficacy of tau immunotherapy in tauopathy. | |
dc.title | Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis | |
dc.type | Article | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/109522/1/12974_2014_Article_152.pdf | |
dc.identifier.doi | 10.1186/s12974-014-0152-0 | en_US |
dc.language.rfc3066 | en | |
dc.rights.holder | Selenica et al.; licensee BioMed Central Ltd. | |
dc.date.updated | 2014-12-08T17:46:55Z | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.